Access to medicine in the global economy : international agreements on patents and related rights

List of Figures and Tables . . vii
Preface . . ix
Acknowledgments . . xi
Introduction . . xiii

PART ONE | BACKGROUND
1. From Conception to Commercial Success . . 3
2. A Limitation on the Patent Right to Exclude: An Introduction to International Exhaustion . . 35

PART TWO | THE CURRENT FRAMEWORK
3. An Introduction to TRIPS . . 55
4. Freedom under TRIPS: India as an Example . . 89
5. Compulsory Licensing under TRIPS: An Introduction . . 125
6. Compulsory License Case Study: An Introduction to Competing Patent Perspectives . . 157
7. Complicated Compulsory Licenses: The Waiver/Article 31 bis "Solution" . . 195

PART THREE | THE EVOLVING FRAMEWORK
8. An Overview of "TRIPS-Plus" Standards . . 223
9. Beyond Patents: Protecting Drugs through Regulatory Laws . . 253
10. Suspensions of In-Transit "Generic Drugs": A Case Study of Competing Perspectives . . 285
11. A History of Access to Medicine through the Lens of Patent Perspectives . . 325
12. Looking Toward the Future . . 355

APPENDICES
Appendix A: Selected TRIPS Provisions . . 375
Appendix B: Declaration on the TRIPS Agreement and Public Health . . 382
Appendix C: Draft Ministerial Declaration (Developed Countries) . . 384
Appendix D: Draft Ministerial Declaration (Developing Countries) . . 386
Appendix E: Glossary of Terms . . 390

INDEX . . 399